Cook GJR, Wong WL, Sanghera B, Mangar S, et al. Eligibility for (177)Lu-PSMA therapy depends on the choice of companion diagnostic tracer: a comparison of (68)Ga-PSMA-11 and (99m)Tc-MIP-1404 in metastatic castrate resistant prostate cancer. J Nucl Med 2022 Oct 27. pii: jnumed.122.264296. doi: 10.2967/jnumed.122.264296.
PMID: 36302657